Viewing Study NCT00675103


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-06-08 @ 7:49 PM
Study NCT ID: NCT00675103
Status: COMPLETED
Last Update Posted: 2011-06-28
First Post: 2008-05-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
Sponsor: Savient Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Gout Refractory to Conventional Therapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gout View
None Gouty Arthritis View
None Anti-Gout preparations View